Table 2.
Structural OCT parameters in the study groups
| Epilepsy Group (n=46) | Control Group (n=50) | p | |
|---|---|---|---|
| Mean RNFL | 96.59±7.9 | 98.84±9.8 | 0.219 |
| Thickness (μm) | (82–114) | (74–120) | |
| CMT (μm) | 221.87±21.8 | 254.5±28.3 | 0.0001** |
| (184–269) | (197–318) | ||
| GCL (μm) | 15.33±4.9 | 16.1±4.6 | 0.423 |
| (6–28) | (7–27) | ||
| The CT of the point 500 μm temporal to the fovea (μm) | 341.22±77.5 (209–542) | 352.88±105 (164–561) | 0.535 |
| The CT of the point 1500 μm Temporal to the fovea (μm) | 322.8±80.2 (146–503) | 343.06±94.5 (151–544) | 0.262 |
| The subfoveal CT (μm) | 349.83±73.7 (223–494)(150–554) | 363.38±110.7 | 0.479 |
| The CT of the point337.48± 79.2 500 μm nasal to(193–518) the fovea (μm) | 351.12±107 (140–555) | 0.483 | |
| The CT of the point280.72± 85 1500 μm nasal to(131–465) the fovea (μm) | 299.84±103.3 (111–527) | 0.327 | |
| TCA (mm²) | 1.18± 0.25 | 3.87± 2.63 | 0.001** |
| (0.71–1.76) | (0.62–3.86) | ||
| LA (mm²) | 0.79±0.15 | 1.01±0.32 | 0.0001** |
| (0.49–1.15) | (0.45–1.70) | ||
| SA (mm²) | 0.38±0.12 | 2.77±2.63 | 0.016* |
| (0.20–0.94) | (1.59–3.86) | ||
| CVI (%) | 0.68±0.04 | 0.68±0.11 | 0.74 |
| (0.46–0.76) | (0.58–0.88) |